Dr. Leonid Slavin, MD

Dr. Slavin practices at Kaiser Permanente San Diego Medical Center in San Diego, California.

Dr. Slavin's NPI, 1255516613, was assigned on January 4, 2008. Dr. Slavin graduated from David Geffen School of Medicine at UCLA in 2005. Dr. Slavin holds California license A97407.

Dr. Slavin's primary practice is Kaiser Permanente San Diego Medical Center, at 9455 Clairemont Mesa Blvd, San Diego, CA 92123 in San Diego County. The practice phone is (619) 528-5000.

Dr. Slavin's primary practice is Kaiser Permanente San Diego Medical Center in San Diego, California. Dr. Slavin is also affiliated with Kaiser Permanente Zion Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Slavin to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Slavin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Slavin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Slavin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Slavin is licensed in California.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Slavin treats.

CMS data shows 47 Medicare services from Dr. Slavin across 3 procedure codes in 2024, for 64 Medicare patients. Medicare paid $1,952 for them.

CMS counts 64 Medicare patients who saw Dr. Slavin in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 47% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Slavin's median patient age at 64, with 58% women.

In 2024, Dr. Slavin wrote 9,119 Medicare Part D claims for 1,229 patients. 80% of them were for generic drugs. CMS names the drug for 8,831 of them, across 65 drugs with 11 or more claims each, at $1,781,247 in total drug cost. In 2023, CMS named 8,078 claims across 60 drugs.

Dr. Slavin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Slavin in 2010. 2010 was the busiest year, with 2. The most frequent topics are Heart Failure and Natriuretic Peptides. Dr. Slavin has published most often in Contrib Nephrol. Dr. Slavin's most frequent co-authors are Alan Maisel, MD, Dinna N. Cruz, MD and Lori Beth Daniels, MD.

CMS Open Payments shows 11 general payments to Dr. Slavin from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $103.

Dmand AI lists 1 award for Dr. Slavin, most recently CMS Stage 1 2012 in 2011.

Dr. Slavin graduated from David Geffen School of Medicine at UCLA in 2005.

Dr. Slavin is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.